✦ LIBER ✦

Selective neck dissection in the management of the neck after (chemo)radiotherapy for advanced head and neck cancer. Proposal for a classification update

✍ Scribed by Marc Hamoir; C.René Leemans; Gilles Dolivet; Sandra Schmitz; Vincent Grégoire; Guy Andry

Publisher: John Wiley and Sons
Year: 2010
Tongue: English
Weight: 78 KB
Volume: 32
Category: Article
ISSN: 1043-3074
DOI: 10.1002/hed.21386

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

For patients with advanced regional disease, neck dissection following (chemo)radiotherapy remains controversial. Selective neck dissection (SND) was reported as suitable after chemoradiation in patients with advanced regional disease. Reduced morbidity represents the major advantage of SND. In a situation in which there is a major fibrosis around the previously invaded nodes, resection of 1 or more nonlymphatic structures may be required. The current classification of SND could be implemented by the addition of extended selective neck dissection (ESND). The standard basic procedures for SND spare the sternocleidomastoid muscle (SCM), the internal jugular vein (IJV), and the spinal accessory nerve (SAN). When an SND is associated with the resection of 1 or more nonlymphatic structures, it should be termed ESND. All additional nonlymphatic structure(s) removed should be identified in parentheses. The proposal to subclassify SND not only in accord with the resected lymph node levels but also upon the nonlymphatic structures removed may be of some help to avoid potential misinterpretation. © 2010 Wiley Periodicals, Inc. Head Neck, 2010

📜 SIMILAR VOLUMES

Management of the neck after alternating

Management of the neck after alternating chemoradiotherapy for advanced head and neck cancer

✍ Giuseppe Sanguineti; Renzo Corvo; Marco Benasso; Giovanni Margarino; MariaPia So 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 77 KB 👁 2 views

Background. To investigate neck control probability and the value of nodal response at completion of alternating chemoradiotherapy, a group of 43 patients was reviewed. Methods. Patients were treated with 60 Gy alternated with four cycles of cisplatin and fluorouracil. All patients had lymph nodes

Isolated neck recurrence after definitiv

Isolated neck recurrence after definitive radiotherapy for node-positive head and neck cancer: Salvage in the dissected or undissected neck

✍ Stanley L. Liauw; Robert J. Amdur; Christopher G. Morris; John W. Werning; Dougl 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 99 KB 👁 1 views

## Abstract ## Background. The role of salvage neck dissection for isolated regional recurrences after definitive radiotherapy (RT) is ill‐defined. ## Methods. Five‐hundred fifty patients were treated with RT for lymph node–positive head and neck cancer. RT consisted of a median dose of 74.4 Gy.

Planned neck dissection after definitive

Planned neck dissection after definitive radiotherapy for squamous cell carcinoma of the head and neck

✍ William M. Mendenhall; Douglas B. Villaret; Robert J. Amdur; Russell W. Hinerman 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 100 KB 👁 2 views

## Abstract ## Background. To define the role of planned neck dissection after definitive radiotherapy for patients with node‐positive squamous cell carcinoma of the head and neck. ## Methods. Review of the pertinent literature. ## Results. Radiotherapy alone produces a relatively high likelih

Utility of positron emission tomography

Utility of positron emission tomography for the detection of disease in residual neck nodes after (chemo)radiotherapy in head and neck cancer

✍ Sandro V. Porceddu; Elizabeth Jarmolowski; Rodney J. Hicks; Rob Ware; LeAnn Weih 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 217 KB 👁 1 views

Background. This study evaluates the utility of fluorine-18 fluorodeoxyglucose positron emission tomography (FDG PET) in patients with a node-positive mucosal head and neck squamous cell carcinoma who achieved a complete response at the primary site but had a residual mass in the neck 8 weeks or mor

Advances in photodynamic therapy for the

Advances in photodynamic therapy for the treatment of head and neck cancers

✍ M. Biel 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 77 KB

## Abstract Photodynamic therapy (PDT) is an FDA‐approved minimally invasive medical treatment modality that utilizes light in the presence of oxygen to activate photosensitizing agents that are relatively selectively concentrated in abnormal or neoplastic cells resulting in cell death. At the pres

Revisiting the role of positron-emission

Revisiting the role of positron-emission tomography/computed tomography in determining the need for planned neck dissection following chemoradiation for advanced head and neck cancer

✍ Christine G. Gourin; Brian J. Boyce; Hadyn T. Williams; Anne V. Herdman; Paul A. 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 148 KB

## Abstract ## Objectives/Hypothesis: Planned neck dissection following chemoradiation (CR) has been advocated in patients with head and neck squamous cell cancer (HNSCC) with advanced nodal disease and a clinical complete response to CR because of the potential for residual occult nodal disease.